Works matching IS 1470269X AND DT 2012 AND VI 12 AND IP 3

Results: 11

Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 260, doi. 10.1038/tpj.2010.93

By:

Tiwari, A K;
Zai, C C;
Likhodi, O;
Voineskos, A N;
Meltzer, H Y;
Lieberman, J A;
Potkin, S G;
Remington, G;
Müller, D J;
Kennedy, J L

Publication type:

Article

Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 227, doi. 10.1038/tpj.2010.88

By:

Olmos, J M;
Zarrabeitia, M T;
Hernández, J L;
Sañudo, C;
González-Macías, J;
Riancho, J A

Publication type:

Article

Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 246, doi. 10.1038/tpj.2010.90

By:

Liu, W;
Downing, A C M;
Munsie, L M;
Chen, P;
Reed, M R;
Ruble, C L;
Landschulz, K T;
Kinon, B J;
Nisenbaum, L K

Publication type:

Article

Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 238, doi. 10.1038/tpj.2011.14

By:

Weber, F;
Cepok, S;
Wolf, C;
Berthele, A;
Uhr, M;
Bettecken, Th;
Buck, D;
Hartung, H P;
Holsboer, F;
Müller-Myhsok, B;
Hemmer, B

Publication type:

Article

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 233, doi. 10.1038/tpj.2010.92

By:

Brunham, L R;
Lansberg, P J;
Zhang, L;
Miao, F;
Carter, C;
Hovingh, G K;
Visscher, H;
Jukema, J W;
Stalenhoef, A F;
Ross, C J D;
Carleton, B C;
Kastelein, J J P;
Hayden, M R

Publication type:

Article

Array-based pharmacogenomics of molecular-targeted therapies in oncology.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 185, doi. 10.1038/tpj.2011.53

By:

Sanoudou, D;
Mountzios, G;
Arvanitis, D A;
Pectasides, D

Publication type:

Article

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 255, doi. 10.1038/tpj.2010.91

By:

Mas, S;
Gassò, P;
Álvarez, S;
Parellada, E;
Bernardo, M;
Lafuente, A

Publication type:

Article

Survey of US public attitudes toward pharmacogenetic testing.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 197, doi. 10.1038/tpj.2011.1

By:

Haga, S B;
O'Daniel, J M;
Tindall, G M;
Lipkus, I R;
Agans, R

Publication type:

Article

Economic impact of a genetic test for cisplatin-induced ototoxicity.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 205, doi. 10.1038/tpj.2011.15

By:

Dionne, F;
Mitton, C;
Rassekh, R;
Brooks, B;
Ross, C;
Hayden, M;
Carleton, B

Publication type:

Article

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 267, doi. 10.1038/tpj.2010.89

By:

Suarez-Kurtz, G;
Genro, J P;
de Moraes, M O;
Ojopi, E B;
Pena, S D J;
Perini, J A;
Ribeiro-dos-Santos, A;
Romano-Silva, M A;
Santana, I;
Struchiner, C J

Publication type:

Article

Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping.

Published in:

Pharmacogenomics Journal, 2012, v. 12, n. 3, p. 214, doi. 10.1038/tpj.2011.8

By:

Matsson, P;
Yee, S W;
Markova, S;
Morrissey, K;
Jenkins, G;
Xuan, J;
Jorgenson, E;
Kroetz, D L;
Giacomini, K M

Publication type:

Article